Dow hits record close as Amgen, Eli Lilly, Disney rally; SpaceX, AMD weigh on Nasdaq
Embed this grade
The letter grade, factuality score, political-lean rating, and social-media sentiment for this report unlock with a free CladFacts account — no card, no trial clock. Already have one? Sign in. The full report below is free to read.
Disagree with this grade or political lean?
Flagging is open to every reader with a free account. Sign in or create one to dispute this report.
Topics in this report
Summary
The Reuters segment reported mixed U.S. stock performance on Wednesday, with the Dow Jones Industrial Average rising about 0.5% to a new record close, the S&P 500 slipping marginally, and the Nasdaq falling over 0.8%. Declines were led by AMD (down 7%) and SpaceX (down nearly 14%) after their quarterly earnings releases. Gains in healthcare and entertainment stocks—Amgen (+4.5% on Q2 sales boost and raised outlook), Eli Lilly (+5% after raising full-year revenue forecast), and Disney (+3.5% on profit beat)—supported the Dow. Analyst Shaina Orsis (noted as founder/CEO of Bonrian/Banríon Capital Management) discussed impending SpaceX lockup expirations starting Thursday, warning of potential selling pressure from insiders monetizing long-held stakes.
Editorial Assessment
The broadcast accurately captured the day's market action, index closes, and specific corporate moves with precise percentages that match real-time data. Viewer perception could be slightly skewed by the headline's emphasis on 'Mideast optimism' as the driver of the Dow record; while de-escalation hopes have been a recurring theme in recent weeks, the segment provided no specific catalyst or oil-price movement to substantiate it as the dominant factor. The SpaceX lockup analysis was well-sourced and timely, correctly noting the post-earnings unlock schedule. Overall, this is a high-quality, factual market summary typical of Reuters, though it lacks deeper context on broader market breadth or how much of the Dow's gain came from its healthcare components versus other factors. No major factual errors or unsupported claims.
Key Moments
Dow added about half a percent to notch another record high close; S&P 500 slipped marginally; Nasdaq dropped more than 0.8%.
Confirmed by multiple sources: Dow closed at 54,349.12 (+0.49%), S&P 500 at 7,723.55 (-0.17%), Nasdaq at 26,363.44 (-0.83%).
AMD fell 7% and SpaceX stumbled nearly 14% following quarterly earnings.
Post-earnings moves reported across financial outlets; SpaceX's drop tied to Q2 results including high capital expenditures.
SpaceX shares could face additional pressure from the expiration of the stock's post-IPO lockup period starting Thursday, with insiders likely to sell.
SpaceX's first earnings were Aug. 4; first lockup tranche (up to ~911M shares, ~20%) unlocks Aug. 6 per pre-announced staggered schedule.
Amgen gained about 4.5% on a second-quarter sales boost; Eli Lilly jumped about 5% after raising full-year revenue forecast.
Amgen reported $10.05B revenue (beat), raised 2026 outlook; Eli Lilly raised full-year guidance after strong Q2 GLP-1 and other drug sales.
Shares of Disney rose roughly 3.5% after beating quarterly profit expectations.
Disney reported fiscal Q3 adjusted EPS of $2.06 (beat $1.86 estimate) with strength in parks and streaming.
Notable Concerns
- Headline attributes Dow record primarily to 'Mideast optimism' without detailing the specific news event or its measured market impact
Sources Consulted
- Dow Jones Industrial Average (^DJI) Charts, Data & News
- US Equity Markets Mixed as SpaceX, AMD Shares Drop
- Amgen Hikes Sales Outlook By $1 Billion After Second-Quarter Smash
- Eli Lilly Q2 2026 earnings beat, raises full-year revenue forecast
- Disney (DIS) earnings Q3 2026
- SpaceX sets earnings date, triggering first big share unlock
- S&P 500 Index Overview